Nate Pile


Nate’s Notes and The Wagmore Advisory Letter

  • Editor, Nate's Notes and the Wagmore Advisory Letter
  • Previously Worked for Legendary Biotech Investor and Analyst, Jim McCamant
  • Degree in Mathematics from U.C. Berkeley

About Nate

While earning a degree in Mathematics from U.C. Berkeley in the early 1990s, Nate Pile also started his investment career following biotech stocks while working for legendary biotech investor and analyst Jim McCamant. He launched his own newsletter, Nate's Notes, 1995 with an eye towards helping individual investors grow their wealth through a common sense, long-term approach to investing, and in the 23 years since, the newsletter has quietly become one of the top-performing newsletters in the industry.

Nate's Articles

The Little River Investment Guide focuses on stocks that offer a combination of growth and income. Here, editor Nate Pile looks at two recent additions to the portfolio — a New York regional bank and a Dallas-based REIT.
You are encouraged to remain as fully invested as you can comfortably be while still sleeping easily at night, asserts Nate Pile, editor of Nate's Notes.
MannKind (MNKD) is probably best known at this point in time for Afrezza, its inhalable form of mealtime insulin; the stock was my Top Pick for 2021 and the shares are up 35% year to date, explains Nate Pile, editor of Nate's Notes.
Our stocks are acting well from a chartist’s perspective; many of them are also likely to benefit from various spending initiatives that are coming out of Washington these days, suggests Nate Pile, editor of Little River Investment Guide.

Newsletter Contributions

Nate's Notes

Since 1995, Editor Nate Pile has been sharing his ideas about the stock market and investing with individual investors around the world… and over the course of the past 25 years, his flagship newsletter (Nate’s Notes) has quietly become one of the top performing investment newsletters in the country.

Learn More
Live Now

Accredited Investors Virtual Expo

October 19 - 21, 2021